Studies on the Metabolic Fate and the Pharmacokinetics of 5-n-Buty1-1-cyclohexy1-2, 4, 6-trioxoperhydropyrimidine (BCP) in Man. IV. Pharmacokinetics of BCP in Man following Oral Administration

Abstract
No abstract available